Read More Markets Options Analyzing JD.com’s Unusual Options Activity By Benzinga Insights Today, 2:54 AM Shares of JD.com (NASDAQ:JD) saw some unusual options activity on Thursday. Following the unusual option alert, the stock price moved down to $70.32. JD
Read More Analyst Ratings News Price Target Goldman Sachs Maintains Buy on Apellis Pharmaceuticals, Raises Price Target to $102 By Benzinga Newsdesk Today, 2:54 AM Goldman Sachs analyst Madhu Kumar maintains Apellis Pharmaceuticals (NASDAQ:APLS) with a Buy and raises the price target from $91 to $102. APLS
Read More Biotech FDA General News OncoCyte Sponsored Study Titled ‘Prospective Trial to Define Outcomes of Patients With Completely Resected Stage I or IIA Non-squamous NSCLC Identified as High, Intermediate, or Low Risk’ Posted To ClinicalTrials.gov, Not Yet Recruiting By Benzinga Newsdesk Today, 2:54 AM https://clinicaltrials.gov/ct2/show/NCT05032352 OCX
Read More Options 10 Consumer Discretionary Stocks Whale Activity In Today’s Session By Benzinga Insights Today, 2:54 AM This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity scanner. AMZN